GenoFocus Inc (187420) - Total Liabilities

Latest as of December 2025: ₩81.08 Billion KRW ≈ $54.95 Million USD

Based on the latest financial reports, GenoFocus Inc (187420) has total liabilities worth ₩81.08 Billion KRW (≈ $54.95 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 187420 cash flow conversion to assess how effectively this company generates cash.

GenoFocus Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how GenoFocus Inc's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are GenoFocus Inc's assets to evaluate the company's liquid asset resilience ratio.

GenoFocus Inc Competitors by Total Liabilities

The table below lists competitors of GenoFocus Inc ranked by their total liabilities.

Company	Country	Total Liabilities
NSTS Bancorp Inc NASDAQ:NSTS	USA	$186.67 Million
PW Consolidated Bhd KLSE:7134	Malaysia	RM171.12 Million
ADVENICA AB F:65R	Germany	€85.34 Million
Universus Photo Imagings Limited NSE:UNIVPHOTO	India	Rs161.00 Million
Nimbus Group AB ST:BOAT	Sweden	Skr792.55 Million
Selva Gida Sanayi AS IS:SELVA	Turkey	TL1.82 Billion
Huvitz Co. Ltd KQ:065510	Korea	₩113.72 Billion
Arrienda Rental Properties SOCIMI SA MC:YARP	Spain	€22.09 Million

Liability Composition Analysis (2014–2025)

This chart breaks down GenoFocus Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is GenoFocus Inc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.98	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GenoFocus Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GenoFocus Inc (2014–2025)

The table below shows the annual total liabilities of GenoFocus Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩81.08 Billion ≈ $54.95 Million	-33.81%
2024-12-31	₩122.49 Billion ≈ $83.01 Million	+71.31%
2023-12-31	₩71.50 Billion ≈ $48.46 Million	-35.01%
2022-12-31	₩110.02 Billion ≈ $74.56 Million	+32.17%
2021-12-31	₩83.24 Billion ≈ $56.41 Million	+13.32%
2020-12-31	₩73.46 Billion ≈ $49.78 Million	+92.90%
2019-12-31	₩38.08 Billion ≈ $25.81 Million	+276.16%
2018-12-31	₩10.12 Billion ≈ $6.86 Million	+70.65%
2017-12-31	₩5.93 Billion ≈ $4.02 Million	+735.70%
2016-12-31	₩709.87 Million ≈ $481.07K	-3.57%
2015-12-31	₩736.18 Million ≈ $498.90K	-89.89%
2014-12-31	₩7.28 Billion ≈ $4.93 Million	--

About GenoFocus Inc

KQ:187420 Korea Specialty Chemicals

Market Cap

$58.05 Million

₩85.66 Billion KRW

Market Cap Rank

#21318 Global

#1355 in Korea

Share Price

₩2940.00

Change (1 day)

+0.17%

52-Week Range

₩2350.00 - ₩3620.00

All Time High

₩17350.00